Measuring transaminases in patients with rheumatoid arthritis on weekly methotrexate: does timing of blood testing matter?
Christopher A. Mecoli(Johns Hopkins University), Clifton O. Bingham(Johns Hopkins University), Nikolay Delev(Bristol-Myers Squibb (Sweden))
Cited by 2
Related Papers
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase <scp>II</scp>, Randomized, <scp>Double‐Blind</scp>, <scp>Placebo‐Controlled</scp> Trial
|Arthritis & Rheumatology|2022|261
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases
|Arthritis Care & Research|2023|203
Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)
|Annals of the Rheumatic Diseases|2018|88
Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1–3 pooled analysis
|Arthritis Research & Therapy|2019|80
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases
|Arthritis & Rheumatology|2023|68